Pure Global AI
Norway flag

Norway medical device registration timeline

Source-linked clocks

Norwegian Medical Products Agency (DMP) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock
0 days6-9 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Norway Medical Device Registration Process

Step-by-step DMP registration process. Total estimated timeline: 6-9 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by DMP. Appoint a EU Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to DMP including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

DMP reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. DMP may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, DMP issues Norway market authorization certificate.

Summary: The Norway medical device registration process through Norwegian Medical Products Agency (DMP) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
FDA 510(k)/PMANo substitute for EU MDR conformity assessment; useful as predicate documentation in the technical file
Key requirements
  • EU/EEA Authorized Representative (for non-EEA manufacturers)
  • Clinical investigation validation: feedback within 15 days of receipt; if invalid, 10 days to comment (+20); final validity within 10 days after resubmission
  • Assessment: decision within 45 days of validation, clock frozen awaiting sponsor information, +20 with experts
  • Transitional MDD rules until EUDAMED is mandatory: notification at least 60 days before start; class III/implantable/long-term invasive IIa/IIb start 60 days after notification unless objected
  • End-of-investigation notification within 15 days; final report within 1 year
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the Norway resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against DMP publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:norway:class-i